| |
| |
|
| Insider
Information: |
Stankovich Thomas |
| Relationship: |
Chief Financial Officer |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
90,437 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,641 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
90,437 |
|
|
| Total
Value |
$2,641 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
14
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
4
|
14
|
| |
|
|
|
Gain/Loss Ratio : |
-4.0
|
-14.0
|
| Percentage
Gain/Loss : |
 -79.7%
|
-965.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Response Genetics Inc |
RGDX |
Vice President and CFO |
2009-12-14 |
67,488 |
2009-12-10 |
0 |
Premium* |
|
|
ReShape Lifesciences Inc |
RSLS |
Chief Financial Officer |
2023-10-25 |
22,949 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RSLS |
ReShape Lifesciences Inc |
Chief Financial OfficerOfficer |
• • – |
2021-06-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,613 |
|
- |
|
| RGDX |
Response Genetics Inc |
Vice President and CFO |
• – – |
2009-12-10 |
4 |
B |
$1.26 |
$5,348 |
D/D |
4,000 |
64,488 |
2.74 |
- |
|
| RGDX |
Response Genetics Inc |
Vice President and CFO |
• – – |
2009-12-11 |
4 |
B |
$1.42 |
$2,868 |
D/D |
2,000 |
66,488 |
2.66 |
- |
|
| RGDX |
Response Genetics Inc |
Vice President and CFO |
• – – |
2009-12-14 |
4 |
B |
$1.22 |
$1,235 |
D/D |
1,000 |
67,488 |
2.66 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2021-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
372,744 |
406,357 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2021-08-20 |
4 |
B |
$3.22 |
$48,285 |
D/D |
15,000 |
17,613 |
2.74 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2021-08-30 |
4 |
B |
$3.43 |
$51,435 |
D/D |
15,000 |
32,613 |
2.74 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2021-09-10 |
4 |
S |
$2.89 |
$139,778 |
D/D |
(48,366) |
357,991 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2021-10-01 |
4 |
S |
$2.76 |
$10,102 |
D/D |
(3,660) |
354,331 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2021-11-18 |
4 |
B |
$2.02 |
$40,400 |
D/D |
20,000 |
370,011 |
2.74 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2021-12-02 |
4 |
S |
$1.83 |
$7,863 |
D/D |
(4,304) |
365,707 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-01-04 |
4 |
S |
$1.78 |
$5,644 |
D/D |
(3,171) |
362,536 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-01-31 |
4 |
S |
$1.22 |
$4,494 |
D/D |
(3,684) |
358,852 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
CFO |
• – – |
2022-02-28 |
4 |
S |
$1.06 |
$3,877 |
D/D |
(3,658) |
355,194 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-04-01 |
4 |
S |
$1.13 |
$5,693 |
D/D |
(5,038) |
350,156 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-05-05 |
4 |
S |
$0.77 |
$3,487 |
D/D |
(4,529) |
345,627 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-05-31 |
4 |
B |
$0.87 |
$18,422 |
D/D |
20,000 |
365,627 |
2.74 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-06-01 |
4 |
S |
$0.96 |
$4,299 |
D/D |
(4,478) |
361,149 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-07-01 |
4 |
S |
$0.55 |
$2,547 |
D/D |
(4,630) |
356,519 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-08-05 |
4 |
S |
$0.47 |
$2,222 |
D/D |
(4,728) |
351,791 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-09-06 |
4 |
S |
$0.39 |
$1,883 |
D/D |
(4,828) |
346,963 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
CFO |
• – – |
2022-10-04 |
4 |
S |
$0.28 |
$2,329 |
D/D |
(8,293) |
338,670 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-11-04 |
4 |
S |
$0.27 |
$2,287 |
D/D |
(8,393) |
332,761 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
364,756 |
697,517 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-11-28 |
4 |
S |
$0.17 |
$61,826 |
D/D |
(364,756) |
332,761 |
0 |
% |
|
39 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
